| Original language | English |
|---|---|
| Journal | Movement Disorders Clinical Practice |
| Volume | 8 |
| Issue number | 6 |
| Pages (from-to) | 972-976 |
| Number of pages | 5 |
| DOIs | |
| Publication status | Published - 08.2021 |
Funding
The study was supported by the German Research Foundation (FOR2488), the German Research Foundation via the Clinician Scientist School Lübeck (DFG‐GEPRIS 413535489), and the Damp Foundation. The authors do not declare any conflicts of interest or competing interests. Martje G. Pauly is funded by the Clinician Scientist School Lübeck. Yorck Hellenbroich has nothing to report. Kathrin Grundmann‐Hauser has nothing to report. Frauke Hinrichs has nothing to report. Katja Lohmann received research funding from the German Research Foundation, the Damp‐Stiftung and the Movement Disorders Society and is member of the GP2 initiative within ASAP ( https://parkinsonsroadmap.org/gp2/ ). Norbert Brüggemann served as a consultant for Censa Pharmaceuticals, Centogene, and Bridgebio and is funded by the German Research Foundation (BR4328.2‐1, GRK1957).